Home > Research Lines > Bronchiectasis non associated to Cystic Fibrosis (BQ-noFQ), Cystic Fibrosis (CF) and immune deficiencies
Bronchiectasis non associated to Cystic Fibrosis (BQ-noFQ), Cystic Fibrosis (CF) and immune deficiencies
Objectives
- To study the epidemiological, clinical and microbiological characteristics of BQ-noFQ
- Study the effect of inflammatory response (local and systemic) in the course of the disease
- Study the effectiveness of nonpharmacological treatment and its implication on the quality of life related to health
Ongoing projects
- To investigate the epidemiology and the clinical-microbiological of BQ-noFQ
- To analyze and compare the effectiveness of airway clearance techniques with different degrees of autonomy in patients with BQ-noFQ
- To evaluate short-term effect of inhaled hyperosmolar agents in patients with BQ-noFQ: tolerability and modification of the rheological properties of secretions
- To study the prognostic value of new biomarkers in exacerbations of BQ-no CF
Achievements
- Recruitment of a respiratory physiotherapist to carry on research protocols in this line of research
- Creating a database of patients with BQ-noFQ
- Fundraising from public and / or private funding
Future challenges
- To evaluate and analyze the clinical impact generated by the innate and adaptive immune response to chronic infection
- To evaluate the impact and long-term effects generated by respiratory therapy (FR) in the progression of the disease in subjects with BQ-noFQ
- To study the cost-effectiveness of long-term pulmonary rehabilitation program in patients with BQ-noFQ
Lines list
